SPYRE THERAPEUTICS, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
SPYRE THERAPEUTICS, INC. (SYRE) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $225.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-04
- SPYRE THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$3.43M.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $3.65M.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $3.12M, a 78.99% decline year-over-year.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $4.41M, a 40.12% decline year-over-year.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$764.00K, a 105.23% decline from fiscal 2024.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $14.61M.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$4.89M.
- SPYRE THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$843.00K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$3.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $225.00K 10-Q · filed 2026-08-04 | $3.35M derived: sum of 3 quarters · filed 2026-08-04 | $7.76M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $3.65M 10-Q · filed 2026-05-05 | $6.78M derived: sum of 2 quarters · filed 2026-05-05 | $11.19M derived: sum of 3 quarters · filed 2026-05-05 | $8.89M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $7.54M derived: sum of 2 quarters · filed 2026-02-19 | $5.23M derived: sum of 3 quarters · filed 2026-08-04 | -$764.00K 10-K · filed 2026-02-19 | |
| 2025-09-30 | $4.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.11M derived: sum of 2 quarters · filed 2026-08-04 | -$3.89M 10-Q · filed 2025-11-04 | $10.98M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | -$2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$8.30M 10-Q · filed 2026-08-04 | $6.57M derived: sum of 3 quarters · filed 2026-08-04 | $13.93M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | -$6.00M 10-Q · filed 2026-05-05 | $8.87M derived: sum of 2 quarters · filed 2026-05-05 | $16.23M derived: sum of 3 quarters · filed 2026-05-05 | $460.00K derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $14.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $22.23M derived: sum of 2 quarters · filed 2026-02-19 | $6.46M derived: sum of 3 quarters · filed 2026-02-19 | $14.61M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $7.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$8.41M derived: sum of 2 quarters · filed 2025-11-04 | -$257.00K 10-Q · filed 2025-11-04 | -$1.15M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-06-30 | -$15.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$7.62M 10-Q · filed 2025-08-05 | -$8.51M derived: sum of 3 quarters · filed 2026-02-19 | -$11.46M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-03-31 | $8.15M 10-Q · filed 2025-05-08 | $7.26M derived: sum of 2 quarters · filed 2026-02-19 | $4.32M derived: sum of 3 quarters · filed 2026-02-19 | $6.42M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2023-12-31 | -$891.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-19 | -$3.83M derived: sum of 2 quarters · filed 2026-02-19 | -$1.73M derived: sum of 3 quarters · filed 2026-02-19 | -$4.89M 10-K · filed 2026-02-19 | |
| 2023-09-30 | -$2.94M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$836.00K derived: sum of 2 quarters · filed 2024-11-18 | -$4.00M 10-Q/A · filed 2024-11-18 | -$3.55M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $2.11M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | -$1.06M 10-Q/A · filed 2024-11-18 | $189.00K 10-Q · filed 2023-08-11 | -$608.00K derived: sum of 3 quarters · filed 2025-02-27 | -$1.02M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$3.16M 10-Q/A · filed 2024-11-18 | -$2.71M derived: sum of 2 quarters · filed 2025-02-27 | -$3.13M derived: sum of 3 quarters · filed 2025-02-27 | -$869.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $450.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $34.00K derived: sum of 2 quarters · filed 2025-02-27 | $2.29M derived: sum of 3 quarters · filed 2025-02-27 | -$843.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.84M derived: sum of 2 quarters · filed 2023-11-09 | -$1.29M 10-Q · filed 2023-11-09 | -$838.00K derived: sum of 4 quarters · filed 2024-11-18 | |
| 2022-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$877.00K 10-Q · filed 2023-08-11 | -$422.00K derived: sum of 3 quarters · filed 2024-11-18 | $617.00K derived: sum of 4 quarters · filed 2024-11-18 | |
| 2022-03-31 | -$3.14M 10-Q · filed 2023-05-11 | -$2.68M derived: sum of 2 quarters · filed 2024-11-18 | -$1.64M derived: sum of 3 quarters · filed 2024-11-18 | -$811.00K derived: sum of 4 quarters · filed 2024-11-18 | |
| 2021-12-31 | $455.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $1.49M derived: sum of 2 quarters · filed 2024-11-18 | $2.33M derived: sum of 3 quarters · filed 2024-11-18 | -$373.00K 10-K/A · filed 2024-11-18 | |
| 2021-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.87M derived: sum of 2 quarters · filed 2022-11-03 | -$828.00K 10-Q · filed 2022-11-03 | $1.65M derived: sum of 4 quarters · filed 2023-03-02 | |
| 2021-06-30 | $833.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.87M 10-Q · filed 2022-08-04 | $608.00K derived: sum of 3 quarters · filed 2023-03-02 | $928.00K derived: sum of 4 quarters · filed 2023-03-02 | |
| 2021-03-31 | -$2.70M 10-Q · filed 2022-05-05 | -$225.00K derived: sum of 2 quarters · filed 2023-03-02 | $95.00K derived: sum of 3 quarters · filed 2023-03-02 | -$1.78M derived: sum of 4 quarters · filed 2023-03-02 | |
| 2020-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $2.79M derived: sum of 2 quarters · filed 2023-03-02 | $919.00K derived: sum of 3 quarters · filed 2023-03-02 | -$1.15M 10-K · filed 2023-03-02 | |
| 2020-09-30 | $320.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$1.56M derived: sum of 2 quarters · filed 2021-11-04 | -$3.62M 10-Q · filed 2021-11-04 | -$1.80M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$3.94M 10-Q · filed 2021-08-05 | -$2.12M derived: sum of 3 quarters · filed 2022-03-08 | $589.00K derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-03-31 | -$2.06M 10-Q · filed 2021-05-10 | -$242.00K derived: sum of 2 quarters · filed 2022-03-08 | $2.46M derived: sum of 3 quarters · filed 2022-03-08 | $4.17M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2019-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $4.53M derived: sum of 2 quarters · filed 2022-03-08 | $6.23M derived: sum of 3 quarters · filed 2022-03-08 | $5.13M 10-K · filed 2022-03-08 | |
| 2019-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.41M derived: sum of 2 quarters · filed 2020-11-05 | $3.30M 10-Q · filed 2020-11-05 | $6.28M derived: sum of 4 quarters · filed 2021-03-18 | |
| 2019-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $595.00K 10-Q · filed 2020-08-10 | $3.58M derived: sum of 3 quarters · filed 2021-03-18 | $4.79M derived: sum of 4 quarters · filed 2021-03-18 | |
| 2019-03-31 | -$1.10M 10-Q · filed 2020-05-07 | $1.88M derived: sum of 2 quarters · filed 2021-03-18 | $3.09M derived: sum of 3 quarters · filed 2021-03-18 | $3.28M derived: sum of 4 quarters · filed 2021-03-18 | |
| 2018-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $4.20M derived: sum of 2 quarters · filed 2021-03-18 | $4.38M derived: sum of 3 quarters · filed 2021-03-18 | $4.17M 10-K · filed 2021-03-18 | |
| 2018-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.40M derived: sum of 2 quarters · filed 2019-11-06 | $1.19M 10-Q · filed 2019-11-06 | $2.37M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | $185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$32.00K 10-Q · filed 2019-08-06 | $1.15M derived: sum of 3 quarters · filed 2020-02-24 | $1.71M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | -$217.00K 10-Q · filed 2019-05-07 | $963.00K derived: sum of 2 quarters · filed 2020-02-24 | $1.52M derived: sum of 3 quarters · filed 2020-02-24 | $1.54M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2017-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $1.74M derived: sum of 2 quarters · filed 2020-02-24 | $1.75M derived: sum of 3 quarters · filed 2020-02-24 | $1.67M 10-K · filed 2020-02-24 | |
| 2017-09-30 | $559.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $573.00K derived: sum of 2 quarters · filed 2018-11-08 | $486.00K 10-Q · filed 2018-11-08 | $1.01M derived: sum of 4 quarters · filed 2019-03-07 | |
| 2017-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$73.00K 10-Q · filed 2018-08-09 | $447.00K derived: sum of 3 quarters · filed 2019-03-07 | $582.00K derived: sum of 4 quarters · filed 2019-03-07 | |
| 2017-03-31 | -$87.00K 10-Q · filed 2018-05-08 | $433.00K derived: sum of 2 quarters · filed 2019-03-07 | $568.00K derived: sum of 3 quarters · filed 2019-03-07 | $1.27M derived: sum of 4 quarters · filed 2019-03-07 | |
| 2016-12-31 | $520.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $655.00K derived: sum of 2 quarters · filed 2019-03-07 | $1.35M derived: sum of 3 quarters · filed 2019-03-07 | $1.83M 10-K · filed 2019-03-07 | |
| 2016-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $834.00K derived: sum of 2 quarters · filed 2017-11-07 | $1.31M 10-Q · filed 2017-11-07 | $1.81M derived: sum of 4 quarters · filed 2018-03-13 | |
| 2016-06-30 | $699.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.17M 10-Q · filed 2017-08-09 | $1.68M derived: sum of 3 quarters · filed 2018-03-13 | $2.27M derived: sum of 4 quarters · filed 2018-03-13 | |
| 2016-03-31 | $475.00K 10-Q · filed 2017-05-09 | $976.00K derived: sum of 2 quarters · filed 2018-03-13 | $1.57M derived: sum of 3 quarters · filed 2018-03-13 | $1.67M derived: sum of 4 quarters · filed 2018-03-13 | |
| 2015-12-31 | $501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $1.10M derived: sum of 2 quarters · filed 2018-03-13 | $1.19M derived: sum of 3 quarters · filed 2018-03-13 | $1.12M 10-K · filed 2018-03-13 | |
| 2015-09-30 | $599.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $692.00K derived: sum of 2 quarters · filed 2016-11-09 | $618.00K 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $19.00K 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | -$74.00K 10-Q · filed 2016-05-19 | ||||
| 2014-12-31 | $303.00K 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |